SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Lightricks challenges AI giants with open-source text-to-video platform

Full list of Israeli high-tech funding rounds in 2024

TailorMed raises $40 million in equity and debt to help patients access critical medications

Why Israeli tech companies are moving to Miami

Buzz

Most popular

Daily

Weekly

1

Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference

2

Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security

3

Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months

4

Mediaocean acquires Innovid for $500M, delisting it from the NYSE

5

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

Cell Therapy

1 stories about Cell Therapy

ג'וליאן אדמס מנכ"ל גמידה

Gamida Cell announces $75 million financing with Highbridge Capital Management

The Israeli company is developing and commercializing cures for blood cancers and serious hematologic diseases